19 Amendments of Cindy FRANSSEN related to 2023/2075(INI)
Amendment 11 #
Motion for a resolution
Citation 6 a (new)
Citation 6 a (new)
Amendment 225 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy on NCDs complemented by action plans for specific NCDs; welcomes national plans and actions already taken against NCDs by Member States; believes however that a special cardiovascular strategy is needed in the light of cardiovascular disease being the number one cause of death in the Union;
Amendment 265 #
Motion for a resolution
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Acknowledges the complex and multifactorial causes of NCDs and that NCDs cannot always be prevented, and that even among preventable NCDs, there are many cases that cannot be explained by preventable risk factors and that many NCDs display a high degree of hereditary risk;
Amendment 295 #
Motion for a resolution
Paragraph 5 – point a
Paragraph 5 – point a
a. implement measures to help tobacco users quit, reduce the rate of new tobacco users, and prevent tobacco use among minors;
Amendment 315 #
Motion for a resolution
Paragraph 5 – point b a (new)
Paragraph 5 – point b a (new)
ba. evaluate, in the framework of the Tobacco Products Directive, which flavours in e-cigarettes are in particular attractive to minors and non-smokers, and to propose a ban on these, and furthermore, to propose a ban on all characteristic flavours in heated tobacco products and novel tobacco products;
Amendment 398 #
Motion for a resolution
Paragraph 8 – point a
Paragraph 8 – point a
a. encourage and help consumers to make informed and healthy choices about food products, for example by adopting a harmonised EU front-of-pack nutritional label based on robust and independent scientific evidence or by implementing fiscal measures at a national level to make healthy food more affordable; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets;
Amendment 402 #
Motion for a resolution
Paragraph 8 – point a
Paragraph 8 – point a
a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets; mainstream physical activities such as walking, cycling, and the practice of sports in urban planning, and put an increased emphasis on physical activity in schools;
Amendment 512 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Regrets the slow implementation of the Chemicals Strategy for Sustainability, and, in particular, expects the REACH Regulation18 to be revised in order to be able to identify all substances of concern manufactured or imported in the EU and to ban their use in the EU if necessary; _________________ 18 Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), OJ L 396, 30.12.2006, p. 1.
Amendment 515 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
13a. Reiterates that chemical exposure is linked to several NCDs; therefore, supports the measures planned in the Chemicals Strategy for Sustainability and the Zero-Pollution Action Plan to reduce citizens’ exposure to harmful chemical products such as carcinogenic, reprotoxic, mutagenic and endocrine-disrupting substances through all different exposure pathways; stresses the need to ensure occupational health for all workers in the EU; calls on the European Commission to propose a revision of all relevant consumer product legislation to ensure these products do not contain chemicals that have any adverse effect on citizens’ health;
Amendment 525 #
Motion for a resolution
Paragraph 13 b (new)
Paragraph 13 b (new)
13b. Supports the ambition of the Farm to Fork Strategy in reducing the use and risk of chemical pesticides by 50% in 2030; calls on the Commission to ensure that the common agricultural policy helps farmers to reduce the use of pesticides and to substitute harmful active substances;
Amendment 556 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare systems; calls for the systematic exchange at the European level of best practice regarding screening for and early detection of NCDs, such as prostate and cervical cancer; welcomes the updated Council recommendation on cancer screening and calls on Member States to implement it diligently;
Amendment 583 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Encourages Member States to reduce undiagnosed NCDs by introducing targeted health checks for high-risk individuals and individuals belonging to vulnerable and marginalised groups, addressing the main shared metabolic risk factors, ensuring quality care and support NCD patients’ self- management; highlights the importance of privacy and medical confidentiality in this regard;
Amendment 603 #
Motion for a resolution
Paragraph 17 a (new)
Paragraph 17 a (new)
17a. Highlights the link between oral health, including pariodental disease and caries, and some NCDs, such as diabetes and cardiovascular diseases, and the potential positive effects on NCDs of improved oral health;
Amendment 634 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Stresses the importance of cost- effective healthcare, so that limited resources are put to the best use and to the use of patients in most need;
Amendment 662 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19a. Notes that NCDs can have a significant negative effect on mental health, and stresses the need for integrated healthcare for concerned patients; stresses that negative stereotypes related to certain NCDs, notably obesity, can be counterproductive in healthcare and prevention while recalling individual responsibility for certain risk factors;
Amendment 704 #
Motion for a resolution
Paragraph 20
Paragraph 20
20. Recalls that patient empowerment and, health literacy, and treatment adherence are crucial for an EU NCD strategy and that treatment and care should be patient- centred; encourages the promotion of well- informed patients who are actively involved in their own treatment and calls for the therapeutic training of caregivers and patients and their empowerment in the care programmes; underlines the importance of therapeutic adherence, in order to lower hospitalisation and mortality rates as well as optimise the impact of medical investments; encourages Member States to provide healthcare professionals with training regarding patient therapeutic education;
Amendment 737 #
Motion for a resolution
Paragraph 22
Paragraph 22
22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to affordable medicines and alleviate medicine shortages, reduce barriers to cross-border business, while strengthening incentives for investment in innovation; underlines that data protection and intellectual property rights are crucial to ensure competitiveness in the EU by incentivising innovators to develop new products and further ongoing research efforts;
Amendment 762 #
Motion for a resolution
Paragraph 23 a (new)
Paragraph 23 a (new)
23a. Highlights that publicly funded research should prioritise promising products and methods characterised by limited commercial interest, non- patentability, and low benefits in scaleability;
Amendment 765 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Calls on the Commission to strengthen support and investment in the development of new innovative medical devices; believes that new technologies can lead to new and better treatments for NCDs; notes the slow uptake of medical devices under the current Medical Devices Regulation and In Vitro Diagnostic Devices Regulation, and welcomes the postponement of application of certain provisions; calls on the Commission to evaluate the specific needs for the pediatric and orphan medical devices sectors, and propose any legislative amendments necessary to ensure the continuous supply for these patient groups;